Herein, we conducted a computational method for dissecting the relationships among genomic alterations of MAP3K8 and patient outcome, as well as protein-protein interaction (PPI) between MAP3K8 and other molecules in ccRCC patients. This evidence concerns the gene MAP3K8 and nonpapillary renal cell carcinoma.